Efficacy and Safety Study of Combination Therapy to Treat Uncomplicated Obesity

NCT00364871 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

410

Enrollment

INDUSTRY

Sponsor class

Conditions

Obesity

Interventions

DRUG: naltrexone and bupropion SR

Sponsor

Orexigen Therapeutics, Inc